Previous 10 | Next 10 |
In spite of the recent pandemic-induced crisis and correction and other challenges this year, the stock market has made a remarkable recovery and is making all-time highs. Obviously, the big question is, where does it go from here? Is it a good time to invest? Let's say you have s...
HQH offers investors a quarterly distribution based on 2% of the NAV. Due to the fund's significant discount, the yield shareholders actually receive is even more attractive. The fund has also been a great performer due to the pandemic. For further details see: HQH: Deep...
We regularly write about multi-basket income strategies. They mostly have similar underlying principles but vary in terms of income needs, growth goals, and risk levels. We will go over our thesis as to how a diversified income method with low volatility could make you financially ind...
Health Care sector has been resilient during the COVID-19 pandemic. Medical Devices companies have been most impacted due to the decline in elective surgeries. Health Care will continue to be driven by (1) demographic, and (2) innovation tailwinds. For further details see: ...
Written by Nick Ackerman, co-produced by Stanford Chemist Section 19(a) Notices can sometimes confuse or be a bit misleading to investors. This can be especially confusing for newer closed-end fund investors that are just getting started. There are so many terms, to begin within investin...
By Nick Kalivas, Senior Equity Product Strategist Health care presents the opportunity to invest in companies that are constantly innovating to improve quality of life and raise productivity. When thinking about growth, many investors default to technology, noting companies like Am...
Foreword Any collection of stocks is more clearly understood when subjected to yield-based (dog catcher) analysis, these dividend-boosted batches are perfect for the Arnold dog catcher process. Here is your August 3 to 24 combined data from Barron's for 112 dividend-paying equities as supp...
Tekla Healthcare Investors ( HQH ) has been a holding of ours for more than four years, and in April we upgraded it to a "Must Own" in the midst of the COVID-19 outbreak, observes income expert Rida Morwa , editor of High Dividend Opportunities . Looking at the closed-end ...
Co-produced with PendragonY Why Invest in Healthcare and Biotech Closed-End Funds? Tekla Healthcare Investors ( HQH ) has been an HDO holding for more than four years, and in April we upgraded it to a "Must Own", in the midst of the COVID-19 outbreak. As a closed-end fund t...
Written by Nick Ackerman, co-produced by Stanford Chemist The last time we visited Tekla Healthcare Investors ( HQH ) was in late February right before the market took a plunge. As I'm sure most investors are aware, this plunge was due to COVID-19. HQH itself had recovered very quickly, ...
News, Short Squeeze, Breakout and More Instantly...
Tekla Healthcare Investors Company Name:
HQH Stock Symbol:
NYSE Market:
2024-04-22 03:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 07:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-23 06:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...